<DOC>
	<DOCNO>NCT01914900</DOCNO>
	<brief_summary>This phase II study preoperative chemotherapy docetaxel , cisplatin 5-fluorouracil ( TPF ) locally advance resectable oral cavity squamous cell cancer . The aim improve rate pathological complete response induction chemotherapy molecular enrich population , consist patient tumour harbour functional p53 protein and/or show low expression beta-tubulin II .</brief_summary>
	<brief_title>Preoperative TPF Chemotherapy Population Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Signed informed consent Males females age &gt; 18 year Histologically prove primary oral cavity squamous cell cancer ( tumour extend oropharynx accept oropharyngeal invasion &lt; 20 % tumour size ) Stage T2 ( T2 stage accept tumour size 3 cm large ) .T3 , N1 N3 T4a N WHO performance status &lt; 1 Availability block Formalin Fixed Paraffin Embedded ( FFPE ) biopsy tumour Radiological image tumour MRI pretherapy Effective contraception male female subject risk conception exists Prior antitumour therapy head &amp; neck cancer ( chemotherapy biological therapy radiotherapy ) Metastatic disease Medical condition contraindicate administration TPF scheme , particular : 1. clinically significant cardiac disease include unstable angina , acute myocardial infarction previous 2 year , congestive heart failure arrhythmia require therapy 2. chronic current infectious disease contraindicate administration chemotherapy cause neutropenia ; know HIV , Hepatitis B C positivity 3. uncontrolled renal , hepatic , neurological , cerebral , psychiatric , haematological , gastrointestinal , pulmonary , vascular endocrine disease could interfere antiblastic treatment Preexisting peripheral neuropathy accord Common Toxicity Criteria ( CTC ) Adverse Event grade &gt; 1 Preexisting ototoxicity grade &gt; 1 Previous diagnosis cancer last 3 year ( situ cervical cancer completely excise basocellular/squamocellular skin cancer always admit ) Previous cancer oral cavity le 2 cm exist primary Breast feeding woman woman positive pregnancy test Visit 0 1 Screening laboratory value : Neutrophils &lt; 1.5 x 109/L Platelets &lt; 100 x 109/L ALT AST &gt; 2.5 time upper limit normal Calculated creatinine clearance &lt; 60 mL/min Weight loss 20 % 3 month precede study Technical unresectability define : T4b stag N ulcerate skin encase internal carotid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>oral cavity cancer</keyword>
	<keyword>induction chemotherapy</keyword>
	<keyword>TP53</keyword>
	<keyword>beta tubulin II</keyword>
</DOC>